Case series reveals allergic contact dermatitis linked to benzalkonium chloride in eye drops, suggesting growing concern for users.
We present three patients who developed allergic contact dermatitis (ACD) from benzalkonium chloride (BAK) in ophthalmic drops. BAK is a preservative commonly found in ophthalmic formulations and there is a rising trend of ACD to this allergen. The irritant and sensitising properties of BAK on the ocular mucosa will be discussed. This paper will also explore BAK allergy from eye drops in patients with atopic dermatitis and those using dupilumab.
No takes yet. Share an insight, caveat, or question.
Kannen et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: